Jimin Gao Selected Research

Jimin Gao Research Topics

Disease

44	Neoplasms (Cancer) 07/2023 - 11/2005
12	Urinary Bladder Neoplasms (Bladder Cancer) 01/2021 - 06/2010
12	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 07/2010
5	Lung Neoplasms (Lung Cancer) 01/2022 - 04/2014
5	Carcinogenesis 01/2020 - 01/2008
5	Infections 02/2019 - 01/2015
4	Neoplasm Metastasis (Metastasis) 01/2020 - 03/2012
3	Multiple Myeloma 07/2023 - 01/2020
3	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 01/2021
3	Pneumonia (Pneumonitis) 01/2022 - 08/2015
3	Hypoxia (Hypoxemia) 11/2017 - 01/2010
2	Tuberculosis (Tuberculoses) 07/2020 - 07/2015
2	Hepatocellular Carcinoma (Hepatoma) 05/2020 - 01/2014
2	Virus Diseases (Viral Diseases) 02/2019 - 09/2015
2	Melanoma (Melanoma, Malignant) 01/2019 - 06/2006
2	Bacterial Infections (Bacterial Infection) 06/2016 - 08/2012
2	Cardiomyopathies (Cardiomyopathy) 01/2015 - 09/2010
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2024
1	Cicatrix (Scar) 09/2022
1	Osteoarticular Tuberculosis 07/2020
1	Hyperthermia 05/2020
1	Breast Neoplasms (Breast Cancer) 01/2020
1	Insulin Resistance 01/2020
1	Communicable Diseases (Infectious Diseases) 02/2019
1	Septic Shock (Toxic Shock Syndrome) 02/2019
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2019
1	Cytokine Release Syndrome 06/2018
1	Parkinson Disease (Parkinson's Disease) 11/2017

Drug/Important Bio-Agent (IBA)

20	VaccinesIBA 01/2021 - 06/2006
18	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2005
13	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2021 - 06/2006
9	StreptavidinIBA 01/2021 - 06/2006
6	Chimeric Antigen ReceptorsIBA 07/2023 - 05/2020
4	LigandsIBA 07/2023 - 01/2014
4	Biomarkers (Surrogate Marker)IBA 07/2020 - 02/2019
4	CytokinesIBA 01/2020 - 08/2013
4	AntibodiesIBA 01/2020 - 01/2015
4	Biotin (Vitamin H)FDA Link 12/2019 - 06/2006
3	Interleukin-7 (Interleukin 7)IBA 01/2024 - 01/2021
3	CarcinogensIBA 01/2022 - 02/2009
3	Therapeutic UsesIBA 01/2022 - 10/2017
3	ImmunosorbentsIBA 07/2020 - 08/2013
3	Peptides (Polypeptides)IBA 07/2020 - 06/2005
3	EnzymesIBA 07/2020 - 08/2013
3	Interleukin-2 (IL2)IBA 01/2019 - 09/2011
3	Cancer VaccinesIBA 10/2017 - 05/2011
3	Transcription Factors (Transcription Factor)IBA 02/2014 - 01/2010
2	Neoplasm Antigens (Tumor Antigens)IBA 01/2024 - 05/2011
2	micaIBA 07/2023 - 01/2014
2	Paclitaxel (Taxol)FDA LinkGeneric 04/2019 - 05/2011
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 11/2017 - 07/2013
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2015 - 07/2010
2	Cyclin D1IBA 05/2014 - 07/2013
2	Lipocalin-2IBA 01/2014 - 11/2013
2	arseniteIBA 09/2013 - 01/2008
2	Ethanol (Ethyl Alcohol)IBA 06/2012 - 07/2010
1	CD19-specific chimeric antigen receptorIBA 01/2024
1	Histamine (Histamine Dihydrochloride)FDA Link 07/2023
1	Staphylococcal Protein A (Protein A)IBA 07/2023
1	Granzymes (Granzyme)IBA 07/2023
1	PerforinIBA 07/2023
1	Transforming Growth Factors (Transforming Growth Factor)IBA 09/2022
1	Interleukin-12 (IL 12)IBA 01/2022
1	NectinsIBA 01/2022
1	Glycoproteins (Glycoprotein)IBA 01/2022
1	Benzo(a)pyreneIBA 01/2022
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2021
1	Blood Proteins (Serum Proteins)IBA 07/2020
1	Complement Factor H (Factor H)IBA 07/2020
1	GlypicansIBA 05/2020
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 01/2020
1	Carbon Nanotubes (Carbon Nanotube)IBA 01/2020
1	AdiponectinIBA 01/2020
1	Nonesterified Fatty Acids (NEFA)IBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	Fluorescent Dyes (Fluorescent Probes)IBA 08/2019
1	human AZU1 proteinIBA 02/2019
1	ProcalcitoninIBA 02/2019
1	C-Reactive ProteinIBA 02/2019
1	AvidinIBA 02/2019
1	Amyloid (Amyloid Fibrils)IBA 02/2019
1	norcantharidinIBA 07/2018
1	Combined VaccinesIBA 01/2018
1	Immunoglobulin G (IgG)IBA 10/2017
1	Immune Checkpoint InhibitorsIBA 10/2017
1	IntegrinsIBA 01/2017
1	aspartic acid glycine arginineIBA 01/2017
1	Neutralizing AntibodiesIBA 01/2017
1	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 01/2017
1	Serum-Free Culture MediaIBA 01/2017
1	NickelIBA 10/2016
1	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2016

Therapy/Procedure

16	Therapeutics 01/2022 - 05/2011
10	Immunotherapy 01/2022 - 06/2010
3	Lasers (Laser) 07/2020 - 04/2015
3	Photothermal Therapy 05/2020 - 12/2017
3	Drug Therapy (Chemotherapy) 06/2016 - 05/2011
2	Cell- and Tissue-Based Therapy (Cell Therapy) 07/2023 - 01/2021
2	Aftercare (After-Treatment) 07/2018 - 10/2017
2	Induced Hyperthermia (Thermotherapy) 12/2017 - 06/2016